Center will reconsider the cost of COVAXIN
New Delhi, 21/6 (AO Bureau)The government may reconsider the cost of Covaxin being used in India’s vaccination campaign against the coronavirus. NITI Aayog Member (Health) and Head of National COVID-19 Task Force Dr. VK. Paul indicated this on Monday. He said during an interaction with CNBC TV18, “The central government is paying Bharat Biotech Rs…
